Sustainable Innovation
Practical solutions for payers, sustainable access for patients, and a stronger path forward for transformative medicine.
A Sustainability Crisis for Innovative Medicine
Breakthrough therapies ranging from cell and gene therapies to RNAi-based treatments and beyond—hold the power to change lives. Yet, the very innovation that makes them remarkable also makes them challenging for the healthcare system to support.
Genetic Medicine in Healthcare
Concentrated dosing, rare disease populations, and unpredictable demand create barriers for payers, leaving patients caught between medical breakthroughs and financial realities.
Long-Term Value vs. Payment Today
Traditional financial models such as long-term pharmacoeconomics rarely fit short-term employer health coverage, causing a disconnect between medical progress and real-world access.
A Need for Practical Solutions
The financial strain raises a fundamental question about the future of medicine: what good are life-changing therapies if the healthcare system cannot support them?
ABOUT CURETRUST
Financing and risk solutions designed for specialty, rare, and genetic medicine that align with the operations of insurers, stop-loss carriers, reinsurers, and others paying for innovative medicine.
WHY CURETRUST?
Solutions Right for Complex Medicines
CureTrust was created to bridge this gap. We provide an experience-based risk model that empowers payers to manage the frequency and severity of high-cost drug claims, ensuring patients receive access to the treatments they need most.
In a world of innovative medicine where utilization is uncertain, CureTrust's solution increases sustainability by matching payers' real-world experience.
Through direct integration with payer operations and strategies, CureTrust delivers scalable, practical solutions that balance financial sustainability with patient care—optimizing access for transformative medicine so it can change lives.
Partner with CureTrust
Empower patient access to breakthrough therapies.